DrugPatentWatch Database Preview
Stiefel Company Profile
What is the competitive landscape for STIEFEL, and what generic and branded alternatives to STIEFEL drugs are available?
STIEFEL has five approved drugs.
Summary for Stiefel
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
| Patent Litigation for Stiefel: | See patent lawsuits for Stiefel |
Drugs and US Patents for Stiefel
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stiefel | SCABENE | lindane | LOTION;TOPICAL | 086769-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Stiefel | DUAC | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050741-001 | Aug 26, 2002 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-004 | Aug 6, 2009 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ||||
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-003 | Aug 6, 2009 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ||||
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-002 | Oct 28, 1996 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Stiefel | HYDROCORTISONE | hydrocortisone | CREAM;TOPICAL | 086170-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Stiefel
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Stiefel | DUAC | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050741-001 | Aug 26, 2002 | 5,466,446 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for STIEFEL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Gel | 1% / 5% | ➤ Subscribe | 2008-12-11 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
